qPCR analysis showed that the JAK2-STAT3 signaling pathway was activated in the mutants, and inhibition of JAK2 partially rescued the anemic phenotype, which may be a potential therapeutic drug for ribosomal deficiency-induced anemia. Here, JAK2 is linked to anemia (phenotype).